001     177565
005     20240229133743.0
024 7 _ |a 10.1093/jncics/pkab084
|2 doi
024 7 _ |a pmid:34805742
|2 pmid
024 7 _ |a pmc:PMC8598284
|2 pmc
024 7 _ |a altmetric:115202358
|2 altmetric
037 _ _ |a DKFZ-2021-02632
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mori, Nagisa
|0 0000-0003-1721-4083
|b 0
245 _ _ |a Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
260 _ _ |a Oxford
|c 2021
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1637681016_5433
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Observational studies have consistently reported that postmenopausal hormone therapy use is associated with lower colon cancer risk, but epidemiologic studies examining the associations between circulating concentrations of endogenous estrogens and colorectal cancer have reported inconsistent results.We investigated the associations between circulating concentrations of estrone, estradiol, free estradiol, testosterone, free testosterone, androstenedione, dehydroepiandrosterone (DHEA), progesterone, and sex hormone-binding globulin (SHBG) with colon cancer risk in a nested case-control study of 1028 postmenopausal European women (512 colon cancer cases, 516 matched controls) who were noncurrent users of exogenous hormones at blood collection. Multivariable conditional logistic regression models were used to compute odds ratios and 95% confidence intervals to evaluate the association between circulating sex hormones and colon cancer risk. We also conducted a dose-response meta-analysis of prospective studies of circulating estrone and estradiol with colorectal, colon, and rectal cancer risk in postmenopausal women. All statistical tests were 2-sided.In the multivariable model, a nonstatistically significantly positive relationship was found between circulating estrone and colon cancer risk (odds ratio per log2 1-unit increment = 1.17 [95% confidence interval = 1.00 to 1.38]; odds ratioquartile4-quartile1 = 1.33 [95% confidence interval = 0.89 to 1.97], P trend = .20). Circulating concentrations of estradiol, free estradiol, testosterone, free testosterone, androstenedione, DHEA, progesterone, and SHBG were not associated with colon cancer risk. In the dose-response meta-analysis, no clear evidence of associations were found between circulating estradiol and estrone concentrations with colorectal, colon, and rectal cancer risk.Our observational and meta-analysis results do not support an association between circulating concentrations of endogenous sex hormones and colon or rectal cancer in postmenopausal women.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Keski-Rahkonen, Pekka
|0 0000-0001-9437-3040
|b 1
700 1 _ |a Gicquiau, Audrey
|b 2
700 1 _ |a Rinaldi, Sabina
|0 0000-0002-6846-1204
|b 3
700 1 _ |a Dimou, Niki
|b 4
700 1 _ |a Harlid, Sophia
|0 0000-0001-8540-6891
|b 5
700 1 _ |a Harbs, Justin
|0 0000-0002-4759-2643
|b 6
700 1 _ |a Van Guelpen, Bethany
|b 7
700 1 _ |a Aune, Dagfinn
|0 0000-0002-4533-1722
|b 8
700 1 _ |a Cross, Amanda J
|0 0000-0002-0893-2377
|b 9
700 1 _ |a Tsilidis, Konstantinos K
|0 0000-0002-8452-8472
|b 10
700 1 _ |a Severi, Gianluca
|0 0000-0001-7157-419X
|b 11
700 1 _ |a Kvaskoff, Marina
|0 0000-0002-4557-3772
|b 12
700 1 _ |a Fournier, Agnès
|0 0000-0001-8380-3439
|b 13
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 14
|u dkfz
700 1 _ |a Turzanski-Fortner, Renée
|0 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
|b 15
|u dkfz
700 1 _ |a Schulze, Matthias B
|0 0000-0002-0830-5277
|b 16
700 1 _ |a Jakszyn, Paula
|b 17
700 1 _ |a Sánchez, Maria-Jose
|b 18
700 1 _ |a Colorado-Yohar, Sandra M
|b 19
700 1 _ |a Ardanaz, Eva
|0 0000-0001-8434-2013
|b 20
700 1 _ |a Travis, Ruth
|b 21
700 1 _ |a Watts, Eleanor L
|0 0000-0001-9229-2589
|b 22
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 23
700 1 _ |a Krogh, Vittorio
|0 0000-0003-0122-8624
|b 24
700 1 _ |a Tumino, Rosario
|0 0000-0003-2666-414X
|b 25
700 1 _ |a Sacerdote, Carlotta
|0 0000-0002-8008-5096
|b 26
700 1 _ |a Panico, Salvatore
|b 27
700 1 _ |a Bueno-de-Mesquita, Bas
|b 28
700 1 _ |a Gram, Inger Torhild
|0 0000-0002-0031-4152
|b 29
700 1 _ |a Waaseth, Marit
|b 30
700 1 _ |a Gunter, Marc J
|b 31
700 1 _ |a Murphy, Neil
|b 32
773 _ _ |a 10.1093/jncics/pkab084
|g Vol. 5, no. 6, p. pkab084
|0 PERI:(DE-600)2975772-1
|n 6
|p pkab084
|t JNCI cancer spectrum
|v 5
|y 2021
|x 2515-5091
909 C O |o oai:inrepo02.dkfz.de:177565
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)74a6af8347ec5cbd4b77e562e10ca1f2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-09-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2020-09-11
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-09-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-09-11
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-09-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-09-11
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21